Itai Gat

Dr. Itai Gat


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2023
Verified
Conference Paper
Open access
TNTu Anh Nguyen
Tu Anh Nguyen
WHWei-Ning Hsu
Wei-Ning Hsu
ADAntony D'AVirro
Antony D'AVirro
BSBowen Shi
Bowen Shi
IGItai Gat
Itai Gat
EDEmmanuel Dupoux
Emmanuel Dupoux

25 February 2022 in Human Reproduction
Verified
Journal Article
Open access
PDF file
MYMichal Youngster
Michal Youngster
SASarit Avraham
Sarit Avraham
OYOdelia Yaakov
Odelia Yaakov
MRMoran Landau Rabbi
Moran Landau Rabbi
IGItai Gat
Itai Gat
AKAlon Kedem
Alon Kedem
Does prior severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in women undergoing fertility treatments affect the outcomes of fresh ART cycles? SARS-CoV-2 infection does not affect fresh ART treatment outcomes, except for a possible long-term negative effect on oocyte yield (>180 days postinfection). A single previous study suggested no evidence that a history of asymptomatic or mild SARS-CoV-2 infection in females caused impairment of fresh ART treatment outcomes. Retrospective cohort study, including all SARS-CoV-2 infected women who underwent fresh ART cycles within a year from infection (the first cycle postinfection), between October 2020 and June 2021, matched to non-diagnosed controls. Patients from two large IVF units in Israel who were infected with SARS-CoV-2 and later underwent fresh ART cycles were matched by age to non-diagnosed, non-vaccinated controls. Demographics, cycle characteristics and cycle outcomes, including oocyte yield, maturation rate, fertilization rate, number of frozen embryos per cycle and clinical pregnancy rates, were compared between groups. One hundred and twenty-one infected patients and 121 controls who underwent fresh ART cycles were included. Oocyte yield (12.50 versus 11.29; P = 0.169) and mature oocyte rate (78% versus 82%; P = 0.144) in all fresh cycles were similar between groups, as were fertilization rates, number of frozen embryos per cycle and clinical pregnancy rates (43% versus 40%; P = 0.737) in fresh cycles with an embryo transfer. In a logistic regression model, SARS-CoV-2 infection more than 180 days prior to retrieval had a negative effect on oocyte yield (P = 0.018, Slope = −4.08, 95% CI −7.41 to −0.75), although the sample size was small. A retrospective study with data that was not uniformly generated under a study protocol, no antibody testing for the control group. The study findings suggest that SARS-CoV-2 infection does not affect treatment outcomes, including oocyte yield, fertilization and maturation rate, number of good quality embryos and clinical pregnancy rates, in fresh ART cycles, except for a possible long-term negative effect on oocyte yield when retrieval occurs >180 days post-SARS-CoV-2 infection. Further studies are warranted to support these findings. None. 0010-21-HMC, 0094-21-ASF.

7 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
IGItai Gat
Itai Gat
KTKatelynn Tang
Katelynn Tang
KQKevin Quach
Kevin Quach
VKValeriy Kuznyetsov
Valeriy Kuznyetsov
RARan Antes
Ran Antes
CLClifford Librach
Clifford Librach
High DNA fragmentation index (DFI) may be associated with poor outcome after IVF. Our aim was to determine whether DFI impacts blastocyst quality or clinical outcome. This retrospective study included 134 couples who underwent 177 IVF-ICSI and pre-implantation genetic screening (PGS) cycles during January 1st, 2014—March 31st, 2016 and had documented previous DFI. Group 1 (DFI>30%) encompassed 25 couples who underwent 36 cycles; Group 2 (DFI 15–30%) included 45 couples and 57 cycles; group 3 (DFI<15%) included 64 couples and 83 cycles. Male partners within group 1 were older (45.1 compared to 40.6 and 38.3 years, respectively, p<0.05), had higher BMI (32.4 compared to 26.6 and 25.8 respectively, p<0.05) and lower sperm count and motility (46*106/ml and 35.5%, respectively) compared to groups 2 (61.8*106/ml and 46.6%, respectively) and 3 (75.8*106/ml and 55.1%, respectively, p<0.05). Female parameters including ovarian reserve and response and embryo development were similar. Total numbers of biopsied blastocysts were 116, 175 and 259 in groups 1, 2 and 3, respectively. PGS for 24 chromosomes revealed comparable euploidy rate of 46–50.4%, with a similar morphological classification. No significant differences were found regarding pregnancy rates or pregnancy loss. It seems that DFI doesn't correlate with blastocyst aneuploidy or morphological grading.

20 August 2023
Verified
Conference Paper
Closed access
GYGuy Yariv
Guy Yariv
IGItai Gat
Itai Gat
LWLior Wolf
Lior Wolf
YAYossi Adi
Yossi Adi
ISIdan Schwartz
Idan Schwartz

1 February 2016 in Gynecological Endocrinology
Verified
Journal Article
Closed access
PDF file
IGItai Gat
Itai Gat
SMSonia Blanco Mejia
Sonia Blanco Mejia
HBHanna Balakier
Hanna Balakier
CLClifford L. Librach
Clifford L. Librach
ACAnne Claessens
Anne Claessens
EREdward A.J. Ryan
Edward A.J. Ryan
Objective: The objective of this study is to compare the combination of dehydroepiandrosterone (DHEA) and coenzyme Q10 (CoQ10) (D + C) with DHEA alone (D) in intrauterine insemination (IUI) and in vitro fertilization (IVF) cycles among patients with decreased ovarian reserve. Methods: We retrospectively extracted data from patients charts treated by DHEA with/without CoQ10 during IUI or IVF between February 2006 and June 2014. Prestimulation parameters included age, BMI, day 3 FSH and antral follicular count (AFC). Ovarian response parameters included total gonadotropins dosage, peak serum estradiol, number of follicles > 16 mm and fertilization rate. Clinical outcomes included clinical and ongoing pregnancy rates. Results: Three hundred and thirty IUI cycles involved D + C compared with 467 cycles of D; 78 IVF cycles involved D + C and 175 D. In both IUI and IVF, AFC was higher with D + C compared with D (7.4 ± 5.7 versus 5.9 ± 4.7, 8.2 ± 6.3 versus 5.2 ± 5, respectively, p < 0.05). D + C resulted in a more follicles > 16 mm during IUI cycles (3.3 ± 2.3 versus 2.9 ± 2.2, respectively, p = 0.01), while lower mean total gonadotropin dosage was administered after D + C supplementation compared with D (3414 ± 1141 IUs versus 3877 ± 1143 IUs respectively, p = 0.032) in IVF cycles. Pregnancy and delivery rates were similar for both IUI and IVF. Conclusion: D + C significantly increases AFC and improves ovarian responsiveness during IUI and IVF without a difference in clinical outcome.

27 June 2022 in Andrology
Verified
Journal Article
Closed access
IGItai Gat
Itai Gat
AKAlon Kedem
Alon Kedem
MDMichal Dviri
Michal Dviri
AUAna Umanski
Ana Umanski
MLMatan Levi
Matan Levi
MBMicha Baum
Micha Baum